Get Started in Minutes
How Kesimpta Copay Assistance Works
1 – Check Your Coverage/Benefits Verification
Our team of expert billers finds the best avenues of coverage that minimize out-of-pocket costs.
2 – Transfer Prescription to AmeriPharma
We process your prescription by working with your previous pharmacy or prescriber, making the transition quick and easy.
3 – Prior Authorization
Our team of specialists obtains approval from your insurance companies within 24 to 72 hours.
4 – Copay Assistance & Financial Aid
We secure financial aid and decrease copays, out-of-pocket expenses, and high deductibles. To date, AmeriPharma Specialty Care has secured $55 million in financial assistance for our patients.
5 – Nursing Care Coordination
AmeriPharma puts your schedule and home environment first when scheduling and coordinating one of our specialized nurses for your in-home infusions.
6 – Delivery Coordination
Medications are always delivered in strict compliance with the specific requirements for immune globulin shipping. Next-day and overnight cold-chain deliveries are coordinated around your schedule.
What Is Kesimpta?
Kesimpta is FDA-approved as a treatment for relapsing multiple sclerosis (MS). The primary active ingredient is ofatumumab. While this medication does not cure multiple sclerosis, clinical research suggests that it may help slow the progression of the disease and reduce the risk of relapse. Kesimpta is not available in generic form because it is a biologic medication made from living cells.
Kesimpta comes in a liquid form that is administered monthly via injection under the skin. Patients can administer the medication using a prefilled pen or syringe. With proper training from a medical professional, most patients can administer injections themselves.
How Does Kesimpta Work?
Multiple sclerosis (MS) damages the patient’s nervous system, causing an interruption in the signals that travel from the nerves to other parts of the body. B-cell antigens are part of this degenerative process as the immune system attacks the nerves.
Kesimpta belongs to a class of medications known as CD20 monoclonal antibodies that work by targeting these B-cell antigens. The drug binds to and reduces the number of B-cells to slow nerve damage, helping reduce inflammation and the relapse rate. Kesimpta slows the progression of MS and decreases its symptoms. While MS can affect both adults and children, Kesimpta is only approved for use in adults.
Copay and Financial Assistance
AmeriPharma Specialty Care alleviates financial burdens for patients and their families
Advanced software locates funding sources to match you with top-dollar foundation programs
One of our copay assistance specialists will assist with the application process
Automatic updates will be sent to you and your physician on the status of the funding
Kesimpta Side Effects
Kesimpta has some mild side effects as well as other side effects with more serious health implications. Side effects can include:
- Injection site reactions
- Low immunoglobulin levels
- Upper respiratory infections
Reactions to the injection site are common within the first 24 hours after injection. Patients should contact their healthcare provider if they notice swelling, pain, itching, or redness near the injection site. Flu-like symptoms such as body pain, fatigue, fever, and chills may also occur following injection.
Kesimpta may cause a decrease in immunoglobulins. Medical professionals who prescribe this medication keep a close eye on their patients’ blood levels with regular blood tests.
Kesimpta may result in respiratory tract infections. Patients may have a runny nose, a headache, or a sore throat.
Other side effects may appear. Patients should be vigilant and report any concerns to their healthcare provider.
Directions for Use
Medical professionals who prescribe Kesimpta instruct patients on how to administer it if they wish to do it themselves. Patients may take the injections in the thigh, stomach area, or the outer part of the upper arm. However, the drug should not be injected into any bruised, scaly, or tender site. Patients should also avoid injecting into moles, stretch marks, or other types of scars.
Kesimpta prescriptions come with detailed instructions on how to use the medication. Patients should carefully read and follow the instructions when preparing, injecting, and disposing of the medication.
The recommended dose of Kesimpta is 20 mg via subcutaneous injection weekly for 3 weeks (on weeks 0, 1, and 2). The following week, there is no injection. In week 4, the dose is 20 mg. After that, the injections take place monthly, again at 20 mg. Patients who miss an injection in the first 3 weeks should consult their healthcare professional for guidance. Patients who miss a monthly dose should take it as soon as possible and get back on the monthly schedule.